EMJ 7.3 2022

The September issue of EMJ is out now, and focuses on rare diseases and the challenges associated with their diagnosis and management. This issue showcases fascinating reviews, research articles, and case reports from across medical disciplines, including research into the impact of the COVID-19 pandemic on rare disease diagnostics. An interview with Yann Le Cam, Founder and Chief Executive Officer of EURORDIS-Rare Diseases Europe, highlights sustainability in Europe and the need for patient advocacy in rare disease protocols.